A groundbreaking innovation in medical technology has emerged, offering a non-invasive approach to reaching the intricate depths of the human brain. Researchers from University College London and the University of Oxford have developed an ultrasound device that can precisely target deep brain regions without the need for surgery. This remarkable advancement opens up new avenues for understanding brain function and treating various neurological conditions, including Parkinson's disease, depression, and essential tremor.
The technology, known as transcranial ultrasound stimulation (TUS), overcomes the limitations of traditional methods like electrical or magnetic brain stimulation. TUS can penetrate the skull more effectively, allowing for deeper brain penetration. However, previous TUS systems lacked the precision to target specific brain structures, hindering their practical application.
The new device, resembling a helmet, houses 256 small ultrasound elements that work in unison. These elements emit gentle sound waves, converging at a precise point deep within the brain. This focused stimulation is incredibly small, approximately 1,000 times more targeted than conventional ultrasound systems. A soft plastic face mask ensures stability during use, preventing slight movements that could alter the target area.
The system operates in conjunction with functional magnetic resonance imaging (fMRI), enabling real-time observation of brain activity changes during stimulation. This feature allows researchers to confirm that the correct brain region is being stimulated, rather than relying on guesswork.
In a test involving seven healthy volunteers, the researchers targeted a tiny structure called the lateral geniculate nucleus (LGN) in the brain's center. This area, located within the thalamus, plays a crucial role in visual processing. When the ultrasound was directed at the LGN, brain scans revealed a distinct increase in activity in the visual cortex, the brain region responsible for processing sight.
The study's findings demonstrate the system's precision, as the increase in visual cortex activity disappeared when the ultrasound was turned on but aimed elsewhere. Participants did not report any visual changes during stimulation, yet their brains responded. This non-invasive approach to stimulating specific brain regions is a significant advancement.
The research team also explored the system's potential for longer-lasting effects. They employed a patterned stimulation technique and monitored brain activity post-session. In several participants, visual cortex activity decreased and remained lower for at least 40 minutes, suggesting changes in network functionality over time.
The implications of this technology are far-reaching. Many brain disorders, such as Parkinson's disease, depression, and movement disorders, involve deep brain structures. The ability to influence these areas without surgery could revolutionize patient care, offering a non-invasive alternative to surgical deep brain stimulation.
Dr. Ioana Grigoras of the University of Oxford's Nuffield Department of Clinical Neurosciences emphasized the potential of this novel brain stimulation device. She highlighted its ability to precisely target deep brain structures previously inaccessible through non-invasive methods, particularly in Parkinson's disease treatment.
The research team is already looking beyond the lab, with several members founding NeuroHarmonics, a spinout company from UCL. Their goal is to develop a portable, wearable version of the system, making precise brain stimulation accessible in clinics and research centers worldwide.
The study, supported by various funding bodies, has been published in the journal Nature. While further research is needed to understand the exact mechanisms of ultrasound's impact on neural activity, this breakthrough marks a significant step towards non-invasive deep brain modulation, no longer a distant dream but a demonstrated reality.
